Alnylam Pharmace. sell Biotechhunter
Start price
04.09.20
/
50%
€103.80
Target price
04.11.21
-
Performance (%)
38.73%
End price
15.07.21
€144.00
Summary
This prediction ended on 15.07.21 with a price of €144.00. The price for Alnylam Pharmace. massively increased, which is bad news for the SELL prediction by Biotechhunter. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.470% | 4.470% | 11.660% | 54.182% |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% | 41.869% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% | 70.295% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% | 45.956% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% | 54.178% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.